Hangzhou Alltest Biotech Co., Ltd.

Shanghai Stock Exchange 688606.SS

Hangzhou Alltest Biotech Co., Ltd. Market Capitalization on January 14, 2025: USD 708.21 M

Hangzhou Alltest Biotech Co., Ltd. Market Capitalization is USD 708.21 M on January 14, 2025, a -3.74% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Hangzhou Alltest Biotech Co., Ltd. 52-week high Market Capitalization is USD 844.98 M on April 26, 2024, which is 19.31% above the current Market Capitalization.
Hangzhou Alltest Biotech Co., Ltd. 52-week low Market Capitalization is USD 513.61 M on July 04, 2024, which is -27.48% below the current Market Capitalization.
Hangzhou Alltest Biotech Co., Ltd. average Market Capitalization for the last 52 weeks is USD 676.08 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Shanghai Stock Exchange: 688606.SS

Hangzhou Alltest Biotech Co., Ltd.

CEO	Mr. Fei Gao
IPO Date	March 25, 2021
Location	China
Headquarters	#550, Yinhai Street
Employees	1,093
Sector	Health Care
Industries Biotechnology Chemicals & Advanced Materials Pharmaceuticals

Description

Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and market of in vitro diagnostic reagents worldwide. It offers rapid diagnostic products, including women's health, infectious diseases, drugs, cancer, cardiovascular, and other five series of products. The company is based in Hangzhou, China.

Key trends

Past 5 years